🇺🇸 FDA
Pipeline program

Sheng-Yu-Tang

CMUH104-REC3-066

Unknown other completed

Quick answer

Sheng-Yu-Tang for Acute Leukemia is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Acute Leukemia
Phase
Unknown
Modality
other
Status
completed

Clinical trials